These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5757162)

  • 41. [Effect of I 131 therapy on SH-group serum levels in patients with toxic goiter].
    Semenov VD
    Med Radiol (Mosk); 1970 Jun; 15(6):58-62. PubMed ID: 5468341
    [No Abstract]   [Full Text] [Related]  

  • 42. A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
    Bonnema SJ; Grupe P; Boel-Jørgensen H; Brix TH; Hegedüs L
    Eur J Clin Invest; 2011 Jul; 41(7):693-702. PubMed ID: 21175612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of the autonomous "hot" nodule of the thyroid with 131-I.
    Cárdenas R; Oliva J
    Nucl Med (Stuttg); 1969 Dec; 8(4):339-48. PubMed ID: 5380182
    [No Abstract]   [Full Text] [Related]  

  • 44. Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.
    Feldkamp J; Pascher E; Schott M; Goretzki P; Seissler J; Scherbaum WA
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4250-3. PubMed ID: 11549657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Late results of treatment of toxic goiter with radioactive iodine].
    Islambekov RK; Turakulov JC
    Cas Lek Cesk; 1968 Dec; 107(50):1525-9. PubMed ID: 4179749
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Follow-up study of patients treated surgically for non-toxic goiter and thyrotoxicosis. A 1O year material].
    Solem JH; Tolås P; Wisloff F
    Tidsskr Nor Laegeforen; 1973 Jun; 93(16):1223-5. PubMed ID: 4800553
    [No Abstract]   [Full Text] [Related]  

  • 49. [Radioiodine (131I) as the only treatment of hyperthyroidism. Results of 10 years of experience].
    Hennen G; McNamara EM; Dockier A; Joachim M
    Rev Med Liege; 1999 Jul; 54(7):611-7. PubMed ID: 10495684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radioactive iodine treatment of patients with relapsing toxic goiter].
    Iaroslavtsev SA
    Klin Med (Mosk); 1968 Sep; 46(9):106-10. PubMed ID: 5756042
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hypothyroidism following radioiodine therapy].
    Vasiukova EA; Khaĭkina MB; Petrova MM; Kurbatova LI
    Klin Med (Mosk); 1969 Aug; 47(8):25-7. PubMed ID: 5373406
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the increase of urinary radioactivity after administration of tapazole in subjects pretreated with radioiodine. I. Behavior in hyperthyroidism and in simple sporadic goiter].
    Minozzi M; Faggiano M; Nunziata V; Bianco A
    Folia Endocrinol; 1966 Aug; 19(4):452-63. PubMed ID: 4170448
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes of poststimulatory plasma renin activity in women with hyperthyroidism or hypothyroidism in relation to therapy.
    Marcisz C; Kucharz EJ; Marcisz-Orzel M; Poręba R; Orzel A; Sioma-Markowska U
    Neuro Endocrinol Lett; 2011; 32(3):301-7. PubMed ID: 21712789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism.
    Bogazzi F; Bartalena L; Brogioni S; Scarcello G; Burelli A; Campomori A; Manetti L; Rossi G; Pinchera A; Martino E
    J Clin Endocrinol Metab; 1999 Feb; 84(2):499-503. PubMed ID: 10022407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Triiodothyronine (T 3 ) toxicosis". Its role in Graves' disease.
    Ivy HK; Wahner HW; Gorman CA
    Arch Intern Med; 1971 Oct; 128(4):529-34. PubMed ID: 5000048
    [No Abstract]   [Full Text] [Related]  

  • 56. [The state of the peripheral blood and bone marrow in patients with diffuse toxic goiter during radioiodine therapy].
    Dozorets IuL; Perlin MS; Popova LI; Eĭdel' II
    Med Radiol (Mosk); 1967 Apr; 12(4):41-4. PubMed ID: 6052182
    [No Abstract]   [Full Text] [Related]  

  • 57. Red blood cell content of water, sodium and potassium in body fluid disturbances.
    Czaczkes JW; Aviram A; Keynan A; Ullmann TD
    Isr J Med Sci; 1967; 3(1):137-42. PubMed ID: 6030416
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic results of radioiodine therapy of hyperthyroid thyroid gland diseases].
    Debrand-Passard A; Barzen G; Richter W; Wenzel KW; Felix R
    Med Klin (Munich); 1994 Jun; 89(6):319-23. PubMed ID: 8072455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of obsidan on blood electrolyte content in toxic goiter].
    Shikhsaidov II
    Probl Endokrinol (Mosk); 1981; 27(4):3-6. PubMed ID: 6895254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.